Dream Pharma announces exclusive distribution agreement with Nihon Nohyaku for luliconazole
Published: 2007-10-01 06:56:00
Updated: 2007-10-01 06:56:00
Dream Pharma Corporation announced on September 27 the execution of license agreement with Nihon Nohyaku Co. (Tokyo, Japan), an agrochemical and pharmaceutical manufacturer, granting Janus for an exclusive development and sales of a novel antifungal drug "luliconazole" in Korea.
Luliconazole w...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
